Chudova Darya 4

What Happened

• Darya Chudova, Chief Technology Officer of Guardant Health (GH), had 10,714 performance-based restricted stock units convert to common shares on March 15, 2026. The conversion shows an acquisition at $0 (typical for vested RSUs).
• To satisfy tax withholding, the company retained (disposed) 5,759 of those shares at $85.49 per share, totaling $492,337. Net shares delivered to Chudova after withholding: 4,955 shares.
• This is an award/vesting event (not an open-market purchase). The withholding is a routine tax-related disposition rather than an independent sale for cash by the insider.

Key Details

• Transaction date: March 15, 2026; Filing date: March 17, 2026 (filed within the typical Form 4 window).
• Conversion/Vesting: 10,714 shares (code M) at $0.00 — reflects conversion of performance RSUs into common stock.
• Tax withholding: 5,759 shares (code F) disposed at $85.49/share = $492,337 retained by the company to cover taxes (footnote F1).
• Net shares received: 10,714 vested − 5,759 withheld = 4,955 shares delivered to the insider.
• Shares owned after the transaction: not reported in the provided filing excerpt.
• Footnotes: F2 confirms these were performance-based RSUs granted June 7, 2023 with a 3-year performance metric; the second tranche vested on March 15, 2026. F1 notes the withholding amount was not in excess of the tax liability. F3 not applicable.

Context

• This was a vesting/award event (performance RSUs met the metric) and the share retention was to cover tax obligations — a common, administrative action. It should not be read as an independent market sell decision by the insider.
• Because the reported acquisition price is $0.00, these are not option exercises requiring cash payment but conversion/vesting of RSUs.